We have identified that targeting glutamine metabolism increases the primed state of the cell by increasing BIM binding to BCL-2 even across MM cells that are MCL-1 dependent i.e. having BIM bound primarily to MCL-1 [119]. This evidence concerns the gene BCL2 and Miyoshi myopathy.